NCT04765488

Brief Summary

Inhalation anesthesia is the most frequently used technique and is performed in around 70% of surgeries worldwide. Sevoflurane is the most frequently used halogenated anesthetic and is used in 2/3 of the cases. The anesthetic strength of inhalation agents was established in the classic work of Eger and colleagues who determined the minimum alveolar concentration (MAC) of an inhaled anesthetic at atmospheric pressure, necessary to prevent a motor reaction in response to a pain stimulus in 50% of patients. Agitation is a frequent anesthesia complications and it not only lengthens the period of post anesthetic awakening and need for advance monitoring of the patient, but may be a predisposing factor in the development of postoperative delirium (POD) and postoperative cognitive dysfunction (POCD) which are independent predictors of increased mortality, prolonged treatment in the ICU and hospital, and prolonged social adaptation of the operated patients.(The ability of the patient to serve themselves independently.). There is a fairly popular point of view that there is no specific prophylaxis or treatment of postoperative agitation. However, a variant of anesthesia induction with sevoflurane was recently proposed, which reduced the frequency of agitation in children from 24.7% to 4.4%. The technique consisted in interrupting anesthesia at the moment of loss of consciousness, awakening the patient and subsequently performing re-induction. Since this technique might be time consuming in the busiest period of a surgical theatre and not safe if performed with the airways still unsecured it is advisable to shift the Wash In/Wash Out procedure to the stage of awakening at the end of surgery.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 21, 2021

Completed
17 days until next milestone

Study Start

First participant enrolled

March 10, 2021

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2026

Completed
Last Updated

July 8, 2025

Status Verified

June 1, 2025

Enrollment Period

4 years

First QC Date

February 15, 2021

Last Update Submit

July 2, 2025

Conditions

Keywords

emergence agitationpostoperative agitationpostoperative deliriumpostoperative cognitive dysfunction

Outcome Measures

Primary Outcomes (2)

  • The effect of "Wash In / WashOut" procedure on the incidence of postoperative agitation after anesthesia with sevoflurane.

    the patient scores +2 or more points on the RASS scale in one or more measurements, then he is diagnosed with agitation.

    during 30 minutes after awaking

  • To estimate changes in the incidence of postoperative agitation on the RASS scale

    incidence of postoperative agitation in control group - incidence of postoperative agitation in study group

    during 30 minutes after awaking

Secondary Outcomes (6)

  • To estimate changes in the incidence of postoperative delirium on the scales CAM-ICU, ICDSC

    3 days after surgery twice a day (a.m. and p.m.)

  • To estimate changes in the incidence of postoperative cognitive impairment

    on the 7th day after surgery

  • To estimate the incidence of postoperative nausea and vomiting, the need of using of antiemetics

    Since end of surgery prior to hospital discharge

  • To estimate patient satisfaction with anesthesia on the ISAS scale

    At third postoperative day

  • Length of stay in ICU

    ICU discharged

  • +1 more secondary outcomes

Study Arms (2)

Study group

EXPERIMENTAL

A group of patients in relation to whom the "Wash In / WashOut" procedure will be applied. In this group we stop the supply of sevoflurane to the first signs of awakening and record the level of sevoflurane , then we resume the supply of sevoflurane to the end-tidal concentration of 1 MAC maintain the anesthesia for 5 min and stop the supply of sevoflurane to the first signs of awakening again, then we resume the supply of sevoflurane to the end-tidal concentration of 1 MAC maintain the anesthesia for 5 min and finally ( the third time) stop supplying sevoflurane and extubate patient after recovery of muscle tone, spontaneous breathing and consciousness.

Procedure: WashIn /WashOut

Control group

NO INTERVENTION

A group of patients in relation to whom will be applied the traditional method of recovery from anesthesia. In this group during the period of awakening we stop supplying sevoflurane and extubate patient after recovery of muscle tone, spontaneous breathing and consciousness.

Interventions

According "Wash In / WashOut" procedure in study group we stop the supply of sevoflurane to the first signs of awakening and record the level of sevoflurane , then we resume the supply of sevoflurane to the end-tidal concentration of 1 MAC maintain the anesthesia for 5 min and stop the supply of sevoflurane to the first signs of awakening again, then we resume the supply of sevoflurane to the end-tidal concentration of 1 MAC maintain the anesthesia for 5 min and finally ( the third time) stop supplying sevoflurane and extubate patient after recovery of muscle tone, spontaneous breathing and consciousness.

Study group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written informed consent from participants
  • Age ≥ 18 years
  • Planned open abdominal surgery
  • General anesthesia

You may not qualify if:

  • Pregnant patients and breastfeeding patients
  • Mental disorders
  • Epilepsy, Parkinson disease, Alzheimer, peripheral nerve and neuromuscular junction pathology (amyotrophic lateral sclerosis, Guillain-Barre Syndrome, myasthenia gravis et cet.)
  • Use of antidepressants, antipsychotics, sedatives, psychoactive drugs within a month before surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Moscow Scientific Clinical Center

Moscow, 111123, Russia

Location

Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy

Moscow, 129110, Russia

Location

Clinical hospital №1 of the I.M. Sechenov First Moscow State Medical University (Sechenov University)

Moscow, Russia

Location

MeSH Terms

Conditions

Emergence DeliriumPostoperative Cognitive Complications

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental DisordersCognitive DysfunctionCognition Disorders

Study Officials

  • Valery Likhvantsev

    I.M. Sechenov First Moscow State Medical University (Sechenov University); Head of Research V. Negovsky Reanimatology Research Institute

    STUDY DIRECTOR
  • Giovanni Landoni

    San Raffaele Scientific Institute

    STUDY CHAIR
  • Pavel Bagdasarov

    I.M. Sechenov First Moscow State Medical University (Sechenov University)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2021

First Posted

February 21, 2021

Study Start

March 10, 2021

Primary Completion

February 25, 2025

Study Completion

February 25, 2026

Last Updated

July 8, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Our Local Ethical Committee disable us to do it

Locations